Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 1023-1030

  Kalache, Safa ^a   Dinavahi, Rajani ^a   Pinney, Sean ^a   Mehrotra, Anita ^a   Cunningham, Madeleine W ^b   Heeger, Peter S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCINEURIN INHIBITOR; CARDIAC MYOSIN ANTIBODY; HLA ANTIBODY; MYOSIN ANTIBODY; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIAC MYOSINS; CHRONIC DISEASE; COMPLEMENT C4B; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; PILOT PROJECTS; T-LYMPHOCYTE SUBSETS;

EID: 79960513239     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004195     Document Type: Article

References (44)

1. Johnston, D. R., M. H. Sayegh, and J. C. Madsen. 2002. Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance. Front. Biosci. 7: e116-e118.
2. Mehra, M. R. 2006. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am. J. Transplant. 6: 1248-1256.
3. + T cells through the indirect presentation pathway in vivo. J. Immunol. 171: 6510-6518.
4. Sahara, H., T. Shoji, C. Y. Ng, M. J. Weiss, A. Muniappan, D. A. Guenther, S. L. Houser, A. C. Pujara, J. K. Sayre, J. C. Wain, et al. 2006. The role of indirect recognition of MHC class I and II allopeptides in a fully mismatched miniature swine model of lung transplantation. Transplant. Proc. 38: 3256-3258.
5. Terasaki, P. I., and J. Cai. 2008. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 86: 377-383.
6. Poggio, E. D., M. Roddy, J. Riley, M. Clemente, D. E. Hricik, R. Starling, J. B. Young, B. Gus, M. H. Yamani, and P. S. Heeger. 2005. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J. Heart Lung Transplant. 24: 1606-1613.
7. Tellides, G., D. A. Tereb, N. C. Kirkiles-Smith, R. W. Kim, J. H. Wilson, J. S. Schechner, M. I. Lorber, and J. S. Pober. 2000. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature 403: 207-211.
8. Galvin, J. E., M. E. Hemric, S. D. Kosanke, S. M. Factor, A. Quinn, and M. W. Cunningham. 2002. Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am. J. Pathol. 160: 297-306.
9. Li, Y., J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham. 2004. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J. Immunol. 172: 3225-3234.
10. Li, Y., J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham. 2005. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am. J. Pathol. 167: 5-15.
11. Li, Y., J. S. Heuser, L. C. Cunningham, S. D. Kosanke, and M. W. Cunningham. 2006. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J. Immunol. 177: 8234-8240.
12. Zhang, P., C. J. Cox, K. M. Alvarez, and M. W. Cunningham. 2009. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J. Immunol. 183: 27-31.
13. Ellis, N. M., D. K. Kurahara, H. Vohra, A. Mascaro-Blanco, G. Erdem, E. E. Adderson, L. G. Veasy, J. A. Stoner, E. Tam, H. R. Hill, et al. 2010. Priming the immune system for heart disease: a perspective on group A streptococci. J. Infect. Dis. 202: 1059-1067.
14. Ellis, N. M., Y. Li, W. Hildebrand, V. A. Fischetti, and M. W. Cunningham. 2005. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J. Immunol. 175: 5448-5456.
15. Pearl, J. P., J. Parris, D. A. Hale, S. C. Hoffmann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, and A. D. Kirk. 2005. Immuno-competent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5: 465-474.
16. Valujskikh, A. 2006. The challenge of inhibiting alloreactive T-cell memory. Am. J. Transplant. 6: 647-651.
17. Valujskikh, A., and F. G. Lakkis. 2003. In remembrance of things past: memory T cells and transplant rejection. Immunol. Rev. 196: 65-74.
18. Morgun, A., N. Shulzhenko, C. S. Unterkircher, R. V. Diniz, A. B. Pereira, M. S. Silva, S. K. Nishida, D. R. Almeida, A. C. Carvalho, M. Franco, et al. 2004. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. J. Heart Lung Transplant. 23: 204-209. (Pubitemid 38175298)
19. Fedoseyeva, E. V., F. Zhang, P. L. Orr, D. Levin, H. J. Buncke, and G. Benichou. 1999. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J. Immunol. 162: 6836-6842. (Pubitemid 29309412)
20. Ciubotariu, R., Z. Liu, A. I. Colovai, E. Ho, S. Itescu, S. Ravalli, M. A. Hardy, R. Cortesini, E. A. Rose, and N. Suciu-Foca. 1998. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J. Clin. Invest. 101: 398-405.
21. Rolls, H. K., K. Kishimoto, B. M. Illigens, V. Dong, M. H. Sayegh, G. Benichou, and E. V. Fedoseyeva. 2001. Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection. Transplant. Proc. 33: 3821-3822.
22. Nath, D. S., H. Ilias Basha, V. Tiriveedhi, C. Alur, D. Phelan, G. A. Ewald, N. Moazami, and T. Mohanakumar. 2010. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J. Heart Lung Transplant. 29: 1277-1285.
23. Mehra, M. R., M. G. Crespo-Leiro, A. Dipchand, S. M. Ensminger, N. E. Hiemann, J. A. Kobashigawa, J. Madsen, J. Parameshwar, R. C. Starling, and P. A. Uber. 2010. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. [Published erratum appears in 2011 J. Heart Lung Transplant. 30:360.] J. Heart Lung Transplant. 29: 717-727.
24. Sawinski, D., J. Uribarri, D. Peace, T. Yao, P. Wauhop, P. Trzcinka, K. Ostrow, E. D. Poggio, and P. S. Heeger. 2010. 25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. Am. J. Transplant. 10: 2287-2295.
25. Poggio, E. D., M. Clemente, D. E. Hricik, and P. S. Heeger. 2006. Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J. Am. Soc. Nephrol. 17: 564-572.
26. Mascaro-Blanco, A., K. Alvarez, X. Yu, J. Lindenfeld, L. Olansky, T. Lyons, D. Duvall, J. S. Heuser, A. Gosmanova, C. J. Rubenstein, et al. 2008. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 41: 442-453.
27. Soleimani, B., R. I. Lechler, P. I. Hornick, and A. J. George. 2006. Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation. Am. J. Transplant. 6: 1781-1785.
28. Rodriguez, D. S., E. Jankowska-Gan, L. D. Haynes, G. Leverson, A. Munoz, D. Heisey, H. W. Sollinger, and W. J. Burlingham. 2004. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am. J. Transplant. 4: 537-543.
29. Valantine, H. 2004. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J. Heart Lung Transplant. 23(Suppl. 5)S187-S193. (Pubitemid 38496395)
30. Warraich, R. S., A. Pomerance, A. Stanley, N. R. Banner, M. J. Dunn, and M. H. Yacoub. 2000. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 69: 1609-1617.
31. Mahesh, B., H. S. Leong, K. S. Nair, A. McCormack, P. Sarathchandra, and M. L. Rose. 2010. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Transplantation 90: 4-13.
32. Dragun, D., D. N. Müller, J. H. Bräsen, L. Fritsche, M. Nieminen-Kelhä, R. Dechend, U. Kintscher, B. Rudolph, J. Hoebeke, D. Eckert, et al. 2005. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 352: 558-569.
33. Dubel, L., O. Farges, C. Johanet, M. Sebagh, and H. Bismuth. 1998. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 65: 1072-1075. (Pubitemid 28208426)
34. Braghi, S., E. Bonifacio, A. Secchi, V. Di Carlo, G. Pozza, and E. Bosi. 2000. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49: 218-224.
35. Win, T. S., and G. J. Pettigrew. 2010. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 90: 113-120.
36. Iwata, T., A. Philipovskiy, A. J. Fisher, R. G. Presson, Jr., M. Chiyo, J. Lee, E. Mickler, G. N. Smith, I. Petrache, D. B. Brand, et al. 2008. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J. Immunol. 181: 5738-5747.
37. Jurcevic, S., M. E. Ainsworth, A. Pomerance, J. D. Smith, D. R. Robinson, M. J. Dunn, M. H. Yacoub, and M. L. Rose. 2001. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71: 886-892.
38. Fedoseyeva, E. V., K. Kishimoto, H. K. Rolls, B. M. Illigens, V. M. Dong, A. Valujskikh, P. S. Heeger, M. H. Sayegh, and G. Benichou. 2002. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J. Immunol. 169: 1168-1174.
39. Fukami, N., S. Ramachandran, D. Saini, M. Walter, W. Chapman, G. A. Patterson, and T. Mohanakumar. 2009. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J. Immunol. 182: 309-318.
40. Haque, M. A., T. Mizobuchi, K. Yasufuku, T. Fujisawa, R. R. Brutkiewicz, Y. Zheng, K. Woods, G. N. Smith, O. W. Cummings, K. M. Heidler, et al. 2002. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169: 1542-1549. (Pubitemid 34809201)
41. + T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am. J. Transplant. 9: 1784-1795.
42. Zhang, P., C. J. Cox, K. M. Alvarez, and M. W. Cunningham. 2009. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J. Immunol. 183: 27-31.
43. Yung, S., and T. M. Chan. 2008. Anti-DNA antibodies in the pathogenesis of lupus nephritis - the emerging mechanisms. Autoimmun. Rev. 7: 317-321.
44. Heeger, P. S. 2003. T-cell allorecognition and transplant rejection: a summary and update. Am. J. Transplant. 3: 525-533.